Phase 2 Start~month
Phase 2 Start: A Phase IIa, Single-arm, Single-center, Open Label, Proof-of-concept Trial Evaluating Increased Freq
- Drug
- increased
- Indication
- Pancreas Cancer, Metastatic; Pancreas Cancer, Stage IV; Ductal Adenocarcinoma of the Pancreas
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company